Tsafrir Mor

Currently, the major thrust areas in Dr. Mor's laboratory are 1) with the sponsorship of DARPA, the evaluation of transgenic plants as a source for recombinant human acetylcholinesterase to provide protection from non-conventional warfare agents both chemical (organphosphate intoxication) and biological (as an immunomodulator); with NIH support, is to develop plant-derived vaccines against sexually-transmitted diseases with a special focus on Human Immunodeficiency Virus (HIV).